Avanos Medical, Inc. (AVNS): Price and Financial Metrics


Avanos Medical, Inc. (AVNS): $31.78

0.23 (+0.73%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AVNS POWR Grades


  • Value is the dimension where AVNS ranks best; there it ranks ahead of 92.2% of US stocks.
  • The strongest trend for AVNS is in Value, which has been heading up over the past 47 weeks.
  • AVNS ranks lowest in Sentiment; there it ranks in the 10th percentile.

AVNS Stock Summary

  • With a price/earnings ratio of 629.21, Avanos Medical Inc P/E ratio is greater than that of about 99.06% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for Avanos Medical Inc is higher than 95.81% of stocks in our set with a positive cash flow.
  • In terms of twelve month growth in earnings before interest and taxes, Avanos Medical Inc is reporting a growth rate of 233.16%; that's higher than 90.19% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Avanos Medical Inc are POWL, IKNX, ITI, CMCO, and AMRN.
  • Visit AVNS's SEC page to see the company's official filings. To visit the company's web site, go to avanos.com.

AVNS Valuation Summary

  • In comparison to the median Healthcare stock, AVNS's EV/EBIT ratio is 191.13% lower, now standing at -26.7.
  • Over the past 84 months, AVNS's EV/EBIT ratio has gone down 34.9.
  • AVNS's price/earnings ratio has moved up 649.4 over the prior 84 months.

Below are key valuation metrics over time for AVNS.

Stock Date P/S P/B P/E EV/EBIT
AVNS 2021-08-31 2.2 1.2 661.7 -26.7
AVNS 2021-08-30 2.1 1.2 654.9 -26.4
AVNS 2021-08-27 2.1 1.2 660.7 -26.6
AVNS 2021-08-26 2.1 1.2 646.7 -26.1
AVNS 2021-08-25 2.2 1.2 664.7 -26.8
AVNS 2021-08-24 2.1 1.2 653.1 -26.4

AVNS Growth Metrics

  • Its 5 year net income to common stockholders growth rate is now at 95.06%.
  • Its 2 year net income to common stockholders growth rate is now at -125.26%.
  • Its 5 year revenue growth rate is now at -55.73%.
Over the past 70 months, AVNS's revenue has gone down $874,600,000.

The table below shows AVNS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 737.8 14.2 2.4
2021-03-31 715.1 0 -38.5
2020-12-31 714.8 -2.5 -27.2
2020-09-30 719.6 -6.5 13.9
2020-06-30 705.3 -24.2 -16.9
2020-03-31 713.8 -57.2 -21.9

AVNS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AVNS has a Quality Grade of C, ranking ahead of 27.07% of graded US stocks.
  • AVNS's asset turnover comes in at 0.434 -- ranking 109th of 181 Medical Equipment stocks.
  • STAA, SINT, and MASI are the stocks whose asset turnover ratios are most correlated with AVNS.

The table below shows AVNS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.434 0.490 -0.090
2021-03-31 0.416 0.507 -0.081
2020-12-31 0.409 0.522 -0.061
2020-09-30 0.404 0.548 -0.003
2020-06-30 0.396 0.558 -0.027
2020-03-31 0.399 0.568 -0.036

AVNS Stock Price Chart Interactive Chart >

Price chart for AVNS

AVNS Price/Volume Stats

Current price $31.78 52-week high $53.61
Prev. close $31.55 52-week low $30.96
Day low $31.15 Volume 414,800
Day high $31.81 Avg. volume 362,892
50-day MA $34.20 Dividend yield N/A
200-day MA $41.75 Market Cap 1.53B

Avanos Medical, Inc. (AVNS) Company Bio


Avanos Medical, Inc. (formerly Halyard Health) is focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. The company was founded in 2014 and is based in Alpharetta, Georgia.


AVNS Latest News Stream


Event/Time News Detail
Loading, please wait...

AVNS Latest Social Stream


Loading social stream, please wait...

View Full AVNS Social Stream

Latest AVNS News From Around the Web

Below are the latest news stories about Avanos Medical Inc that investors may wish to consider to help them evaluate AVNS as an investment opportunity.

Why Is Avanos Medical (AVNS) Down 2.2% Since Last Earnings Report?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 2, 2021

Is Avanos Medical, Inc. (NYSE:AVNS) Potentially Undervalued?

Avanos Medical, Inc. ( NYSE:AVNS ), might not be a large cap stock, but it saw significant share price movement during...

Yahoo | September 1, 2021

Heartland Advisors Top Detractor: Avanos Medical (AVNS)

No summary available.

Insider Monkey | August 18, 2021

Heartland Advisors’ Top Detractor: Avanos Medical (AVNS)

Heartland Advisors, an investment management firm, published its “Heartland Value Plus Fund” second-quarter 2021 investor letter – a copy of which can be downloaded here. A quarterly portfolio return of 3.35% was recorded by the fund’s Institutional Class for the second quarter of 2021, trailing the Russell 2000® Value Index that delivered a 4.56% return […]

Yahoo | August 18, 2021

Avanos Medical (AVNS) Q2 Earnings Lag Estimates, Revenues Top

Avanos Medical's (AVNS) second-quarter 2021 results gains from strength in Pain Management segment.

Yahoo | August 4, 2021

Read More 'AVNS' Stories Here

AVNS Price Returns

1-mo -5.70%
3-mo -20.05%
6-mo -30.78%
1-year -6.36%
3-year -54.25%
5-year -7.13%
YTD -30.73%
2020 36.14%
2019 -24.76%
2018 -3.01%
2017 24.88%
2016 10.69%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8069 seconds.